⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
globenewswire.com
ALLR
S&P Global brings Credit Ratings to the S&P Global AI Data Portal
prnewswire.com
SPGI
U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
prnewswire.com
ABBV
KRAS Inhibitor Market Projected to Reach $7.8 Billion by 2034
prnewswire.com
LLY
RVMD
ONCY
AMGN
VSTM
Century Casinos, Inc. Enters into Definitive Agreement to Sell Century Mile and Century Downs Racetracks in Alberta, Canada
prnewswire.com
VICI
CNTY
COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR
globenewswire.com
CRK
Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
globenewswire.com
HUMA
Global Neurosciences Institute Performs First SetPoint® System Procedures in Southern New Jersey
prnewswire.com
SPMC
Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden
globenewswire.com
CRNX
Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
globenewswire.com
BCRX